nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—head and neck cancer	0.36	1	CbGaD
Celecoxib—ABCC4—Fluorouracil—head and neck cancer	0.114	0.414	CbGbCtD
Celecoxib—CYP2D6—Hydroxyurea—head and neck cancer	0.0546	0.198	CbGbCtD
Celecoxib—ALB—Fluorouracil—head and neck cancer	0.0423	0.154	CbGbCtD
Celecoxib—CYP2C9—Fluorouracil—head and neck cancer	0.0228	0.0828	CbGbCtD
Celecoxib—CYP2D6—Vinblastine—head and neck cancer	0.0193	0.0701	CbGbCtD
Celecoxib—CA6—submandibular gland—head and neck cancer	0.0172	0.208	CbGeAlD
Celecoxib—CYP3A4—Vinblastine—head and neck cancer	0.0123	0.0446	CbGbCtD
Celecoxib—CYP3A4—Docetaxel—head and neck cancer	0.0101	0.0367	CbGbCtD
Celecoxib—CA6—saliva—head and neck cancer	0.00618	0.0748	CbGeAlD
Celecoxib—CA6—ear—head and neck cancer	0.00565	0.0684	CbGeAlD
Celecoxib—ORM1—saliva—head and neck cancer	0.00329	0.0398	CbGeAlD
Celecoxib—CA6—exocrine gland—head and neck cancer	0.00312	0.0378	CbGeAlD
Celecoxib—CA6—hair follicle—head and neck cancer	0.00298	0.036	CbGeAlD
Celecoxib—MAPK14—hair follicle—head and neck cancer	0.00263	0.0319	CbGeAlD
Celecoxib—CA6—mouth—head and neck cancer	0.00234	0.0283	CbGeAlD
Celecoxib—MAPK14—mouth—head and neck cancer	0.00207	0.025	CbGeAlD
Celecoxib—MAPK14—neck—head and neck cancer	0.00177	0.0214	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—head and neck cancer	0.00173	0.021	CbGeAlD
Celecoxib—CA6—parotid gland—head and neck cancer	0.00163	0.0197	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—head and neck cancer	0.00162	1	CrCbGaD
Celecoxib—PDPK1—thyroid gland—head and neck cancer	0.00157	0.019	CbGeAlD
Celecoxib—CA6—saliva-secreting gland—head and neck cancer	0.00156	0.0189	CbGeAlD
Celecoxib—PTGS2—cartilage tissue—head and neck cancer	0.00146	0.0177	CbGeAlD
Celecoxib—PDPK1—head—head and neck cancer	0.00139	0.0169	CbGeAlD
Celecoxib—MAPK14—connective tissue—head and neck cancer	0.00127	0.0153	CbGeAlD
Celecoxib—MAPK14—epithelium—head and neck cancer	0.0012	0.0145	CbGeAlD
Celecoxib—CA2—exocrine gland—head and neck cancer	0.00108	0.013	CbGeAlD
Celecoxib—CA2—hair follicle—head and neck cancer	0.00102	0.0124	CbGeAlD
Celecoxib—PDPK1—lymph node—head and neck cancer	0.000976	0.0118	CbGeAlD
Celecoxib—CA12—connective tissue—head and neck cancer	0.00096	0.0116	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—head and neck cancer	0.000925	0.0112	CbGeAlD
Celecoxib—CA6—head—head and neck cancer	0.000843	0.0102	CbGeAlD
Celecoxib—MAPK14—thyroid gland—head and neck cancer	0.00084	0.0102	CbGeAlD
Celecoxib—CA4—neck—head and neck cancer	0.000829	0.01	CbGeAlD
Celecoxib—CA12—trachea—head and neck cancer	0.000806	0.00976	CbGeAlD
Celecoxib—CA2—mouth—head and neck cancer	0.000804	0.00974	CbGeAlD
Celecoxib—MAPK14—head—head and neck cancer	0.000746	0.00903	CbGeAlD
Celecoxib—CA2—neck—head and neck cancer	0.000688	0.00833	CbGeAlD
Celecoxib—CA4—parotid gland—head and neck cancer	0.000675	0.00818	CbGeAlD
Celecoxib—CA4—saliva-secreting gland—head and neck cancer	0.000647	0.00783	CbGeAlD
Celecoxib—PTGS2—mouth—head and neck cancer	0.000594	0.00719	CbGeAlD
Celecoxib—CA5B—thyroid gland—head and neck cancer	0.000572	0.00693	CbGeAlD
Celecoxib—CA12—head—head and neck cancer	0.000566	0.00685	CbGeAlD
Celecoxib—CA2—parotid gland—head and neck cancer	0.00056	0.00678	CbGeAlD
Celecoxib—CA2—saliva-secreting gland—head and neck cancer	0.000536	0.0065	CbGeAlD
Celecoxib—Weight increased—Hydroxyurea—head and neck cancer	0.000532	0.00416	CcSEcCtD
Celecoxib—Drug interaction—Docetaxel—head and neck cancer	0.000522	0.00408	CcSEcCtD
Celecoxib—MAPK14—lymph node—head and neck cancer	0.000522	0.00632	CbGeAlD
Celecoxib—Infestation NOS—Hydroxyurea—head and neck cancer	0.000522	0.00408	CcSEcCtD
Celecoxib—Infestation—Hydroxyurea—head and neck cancer	0.000522	0.00408	CcSEcCtD
Celecoxib—Haemoglobin—Vinblastine—head and neck cancer	0.000516	0.00403	CcSEcCtD
Celecoxib—Haemorrhage—Vinblastine—head and neck cancer	0.000514	0.00401	CcSEcCtD
Celecoxib—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000511	0.004	CcSEcCtD
Celecoxib—Hypoaesthesia—Vinblastine—head and neck cancer	0.000511	0.00399	CcSEcCtD
Celecoxib—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00051	0.00398	CcSEcCtD
Celecoxib—Pharyngitis—Vinblastine—head and neck cancer	0.00051	0.00398	CcSEcCtD
Celecoxib—Hearing impaired—Docetaxel—head and neck cancer	0.000509	0.00398	CcSEcCtD
Celecoxib—Stomatitis—Hydroxyurea—head and neck cancer	0.000509	0.00397	CcSEcCtD
Celecoxib—CA5B—head—head and neck cancer	0.000507	0.00614	CbGeAlD
Celecoxib—Cardiac failure—Fluorouracil—head and neck cancer	0.000499	0.0039	CcSEcCtD
Celecoxib—CA4—trachea—head and neck cancer	0.000499	0.00604	CbGeAlD
Celecoxib—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000493	0.00386	CcSEcCtD
Celecoxib—CA2—connective tissue—head and neck cancer	0.000493	0.00597	CbGeAlD
Celecoxib—Osteoarthritis—Fluorouracil—head and neck cancer	0.000487	0.00381	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000487	0.00381	CcSEcCtD
Celecoxib—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000485	0.00379	CcSEcCtD
Celecoxib—Pulmonary embolism—Docetaxel—head and neck cancer	0.000485	0.00379	CcSEcCtD
Celecoxib—Blood pressure increased—Docetaxel—head and neck cancer	0.000485	0.00379	CcSEcCtD
Celecoxib—Injection site reaction—Docetaxel—head and neck cancer	0.000482	0.00376	CcSEcCtD
Celecoxib—Haemoglobin—Hydroxyurea—head and neck cancer	0.000471	0.00368	CcSEcCtD
Celecoxib—Influenza like illness—Docetaxel—head and neck cancer	0.000471	0.00368	CcSEcCtD
Celecoxib—Haemorrhage—Hydroxyurea—head and neck cancer	0.000468	0.00366	CcSEcCtD
Celecoxib—CA2—epithelium—head and neck cancer	0.000468	0.00567	CbGeAlD
Celecoxib—Hallucination—Hydroxyurea—head and neck cancer	0.000466	0.00364	CcSEcCtD
Celecoxib—Colitis—Docetaxel—head and neck cancer	0.000465	0.00364	CcSEcCtD
Celecoxib—Candida infection—Docetaxel—head and neck cancer	0.000463	0.00362	CcSEcCtD
Celecoxib—Skin exfoliation—Docetaxel—head and neck cancer	0.000463	0.00362	CcSEcCtD
Celecoxib—Fluid retention—Docetaxel—head and neck cancer	0.00046	0.0036	CcSEcCtD
Celecoxib—Ataxia—Fluorouracil—head and neck cancer	0.000458	0.00358	CcSEcCtD
Celecoxib—Neuropathy—Docetaxel—head and neck cancer	0.000455	0.00356	CcSEcCtD
Celecoxib—Alopecia—Vinblastine—head and neck cancer	0.000454	0.00355	CcSEcCtD
Celecoxib—Dry skin—Fluorouracil—head and neck cancer	0.000447	0.00349	CcSEcCtD
Celecoxib—Oesophagitis—Docetaxel—head and neck cancer	0.000443	0.00346	CcSEcCtD
Celecoxib—Neoplasm—Docetaxel—head and neck cancer	0.000438	0.00342	CcSEcCtD
Celecoxib—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000436	0.00341	CcSEcCtD
Celecoxib—ABCC4—thyroid gland—head and neck cancer	0.000429	0.0052	CbGeAlD
Celecoxib—Angiopathy—Hydroxyurea—head and neck cancer	0.000425	0.00332	CcSEcCtD
Celecoxib—Dysphagia—Fluorouracil—head and neck cancer	0.000421	0.00329	CcSEcCtD
Celecoxib—Sepsis—Docetaxel—head and neck cancer	0.00042	0.00329	CcSEcCtD
Celecoxib—Eosinophilia—Fluorouracil—head and neck cancer	0.000417	0.00326	CcSEcCtD
Celecoxib—Alopecia—Hydroxyurea—head and neck cancer	0.000414	0.00323	CcSEcCtD
Celecoxib—CA2—trachea—head and neck cancer	0.000414	0.00501	CbGeAlD
Celecoxib—Anaemia—Vinblastine—head and neck cancer	0.000413	0.00323	CcSEcCtD
Celecoxib—Angina pectoris—Fluorouracil—head and neck cancer	0.00041	0.00321	CcSEcCtD
Celecoxib—Thrombophlebitis—Docetaxel—head and neck cancer	0.000406	0.00318	CcSEcCtD
Celecoxib—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000404	0.00316	CcSEcCtD
Celecoxib—Vertigo—Vinblastine—head and neck cancer	0.000402	0.00314	CcSEcCtD
Celecoxib—Leukopenia—Vinblastine—head and neck cancer	0.0004	0.00313	CcSEcCtD
Celecoxib—Pancytopenia—Fluorouracil—head and neck cancer	0.0004	0.00313	CcSEcCtD
Celecoxib—CA4—thyroid gland—head and neck cancer	0.000395	0.00478	CbGeAlD
Celecoxib—Deafness—Docetaxel—head and neck cancer	0.000393	0.00307	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000391	0.00306	CcSEcCtD
Celecoxib—Hepatic failure—Docetaxel—head and neck cancer	0.000391	0.00306	CcSEcCtD
Celecoxib—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000388	0.00303	CcSEcCtD
Celecoxib—Hypertension—Vinblastine—head and neck cancer	0.000386	0.00302	CcSEcCtD
Celecoxib—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000384	0.003	CcSEcCtD
Celecoxib—ABCC4—head—head and neck cancer	0.000381	0.00461	CbGeAlD
Celecoxib—Pneumonia—Fluorouracil—head and neck cancer	0.000378	0.00295	CcSEcCtD
Celecoxib—Anaemia—Hydroxyurea—head and neck cancer	0.000377	0.00295	CcSEcCtD
Celecoxib—Hot flush—Docetaxel—head and neck cancer	0.000376	0.00294	CcSEcCtD
Celecoxib—Infestation—Fluorouracil—head and neck cancer	0.000376	0.00293	CcSEcCtD
Celecoxib—Infestation NOS—Fluorouracil—head and neck cancer	0.000376	0.00293	CcSEcCtD
Celecoxib—Menopausal symptoms—Docetaxel—head and neck cancer	0.000373	0.00291	CcSEcCtD
Celecoxib—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00037	0.00289	CcSEcCtD
Celecoxib—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000368	0.00288	CcSEcCtD
Celecoxib—Myocardial infarction—Fluorouracil—head and neck cancer	0.000368	0.00288	CcSEcCtD
Celecoxib—Dermatitis bullous—Docetaxel—head and neck cancer	0.000368	0.00288	CcSEcCtD
Celecoxib—Stomatitis—Fluorouracil—head and neck cancer	0.000366	0.00286	CcSEcCtD
Celecoxib—Conjunctivitis—Fluorouracil—head and neck cancer	0.000365	0.00285	CcSEcCtD
Celecoxib—Urinary tract infection—Fluorouracil—head and neck cancer	0.000365	0.00285	CcSEcCtD
Celecoxib—Leukopenia—Hydroxyurea—head and neck cancer	0.000365	0.00285	CcSEcCtD
Celecoxib—PTGS2—connective tissue—head and neck cancer	0.000364	0.00441	CbGeAlD
Celecoxib—CA2—lymphoid tissue—head and neck cancer	0.00036	0.00436	CbGeAlD
Celecoxib—Cardiac failure—Docetaxel—head and neck cancer	0.00036	0.00282	CcSEcCtD
Celecoxib—Thrombocytopenia—Vinblastine—head and neck cancer	0.000357	0.00279	CcSEcCtD
Celecoxib—CA5B—lymph node—head and neck cancer	0.000355	0.0043	CbGeAlD
Celecoxib—Epistaxis—Fluorouracil—head and neck cancer	0.000354	0.00277	CcSEcCtD
Celecoxib—Hyponatraemia—Docetaxel—head and neck cancer	0.000353	0.00276	CcSEcCtD
Celecoxib—Sinusitis—Fluorouracil—head and neck cancer	0.000352	0.00275	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000352	0.00275	CcSEcCtD
Celecoxib—Agranulocytosis—Fluorouracil—head and neck cancer	0.00035	0.00274	CcSEcCtD
Celecoxib—CA4—head—head and neck cancer	0.00035	0.00424	CbGeAlD
Celecoxib—Anorexia—Vinblastine—head and neck cancer	0.000348	0.00272	CcSEcCtD
Celecoxib—Migraine—Docetaxel—head and neck cancer	0.000346	0.00271	CcSEcCtD
Celecoxib—PTGS2—epithelium—head and neck cancer	0.000345	0.00418	CbGeAlD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000345	0.00269	CcSEcCtD
Celecoxib—Haemoglobin—Fluorouracil—head and neck cancer	0.000339	0.00265	CcSEcCtD
Celecoxib—Rhinitis—Fluorouracil—head and neck cancer	0.000338	0.00264	CcSEcCtD
Celecoxib—Haemorrhage—Fluorouracil—head and neck cancer	0.000337	0.00263	CcSEcCtD
Celecoxib—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000335	0.00262	CcSEcCtD
Celecoxib—Pharyngitis—Fluorouracil—head and neck cancer	0.000335	0.00261	CcSEcCtD
Celecoxib—Oedema—Hydroxyurea—head and neck cancer	0.000333	0.0026	CcSEcCtD
Celecoxib—Ataxia—Docetaxel—head and neck cancer	0.000331	0.00258	CcSEcCtD
Celecoxib—Infection—Hydroxyurea—head and neck cancer	0.000331	0.00258	CcSEcCtD
Celecoxib—Paraesthesia—Vinblastine—head and neck cancer	0.000328	0.00256	CcSEcCtD
Celecoxib—CA2—thyroid gland—head and neck cancer	0.000327	0.00396	CbGeAlD
Celecoxib—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000326	0.00255	CcSEcCtD
Celecoxib—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000326	0.00255	CcSEcCtD
Celecoxib—Liver function test abnormal—Docetaxel—head and neck cancer	0.000325	0.00254	CcSEcCtD
Celecoxib—Skin disorder—Hydroxyurea—head and neck cancer	0.000323	0.00253	CcSEcCtD
Celecoxib—Dry skin—Docetaxel—head and neck cancer	0.000322	0.00252	CcSEcCtD
Celecoxib—Abdominal pain upper—Docetaxel—head and neck cancer	0.000321	0.00251	CcSEcCtD
Celecoxib—Breast disorder—Docetaxel—head and neck cancer	0.000318	0.00248	CcSEcCtD
Celecoxib—Anorexia—Hydroxyurea—head and neck cancer	0.000317	0.00248	CcSEcCtD
Celecoxib—Decreased appetite—Vinblastine—head and neck cancer	0.000317	0.00248	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000317	0.00248	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000317	0.00248	CcSEcCtD
Celecoxib—Nasopharyngitis—Docetaxel—head and neck cancer	0.000315	0.00246	CcSEcCtD
Celecoxib—ORM1—lymph node—head and neck cancer	0.000314	0.00381	CbGeAlD
Celecoxib—Constipation—Vinblastine—head and neck cancer	0.000312	0.00244	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00031	0.00242	CcSEcCtD
Celecoxib—PTGS2—trachea—head and neck cancer	0.000305	0.0037	CbGeAlD
Celecoxib—Dysphagia—Docetaxel—head and neck cancer	0.000304	0.00238	CcSEcCtD
Celecoxib—Arrhythmia—Fluorouracil—head and neck cancer	0.000301	0.00235	CcSEcCtD
Celecoxib—Feeling abnormal—Vinblastine—head and neck cancer	0.000301	0.00235	CcSEcCtD
Celecoxib—Bronchospasm—Docetaxel—head and neck cancer	0.000299	0.00234	CcSEcCtD
Celecoxib—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000298	0.00233	CcSEcCtD
Celecoxib—Alopecia—Fluorouracil—head and neck cancer	0.000298	0.00233	CcSEcCtD
Celecoxib—Dyspnoea—Hydroxyurea—head and neck cancer	0.000297	0.00232	CcSEcCtD
Celecoxib—Angina pectoris—Docetaxel—head and neck cancer	0.000296	0.00231	CcSEcCtD
Celecoxib—Somnolence—Hydroxyurea—head and neck cancer	0.000296	0.00231	CcSEcCtD
Celecoxib—Dyspepsia—Hydroxyurea—head and neck cancer	0.000293	0.00229	CcSEcCtD
Celecoxib—CA2—head—head and neck cancer	0.00029	0.00352	CbGeAlD
Celecoxib—Decreased appetite—Hydroxyurea—head and neck cancer	0.000289	0.00226	CcSEcCtD
Celecoxib—Pancytopenia—Docetaxel—head and neck cancer	0.000289	0.00226	CcSEcCtD
Celecoxib—Abdominal pain—Vinblastine—head and neck cancer	0.000288	0.00225	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000287	0.00225	CcSEcCtD
Celecoxib—Fatigue—Hydroxyurea—head and neck cancer	0.000287	0.00224	CcSEcCtD
Celecoxib—Constipation—Hydroxyurea—head and neck cancer	0.000285	0.00222	CcSEcCtD
Celecoxib—Weight increased—Docetaxel—head and neck cancer	0.000277	0.00216	CcSEcCtD
Celecoxib—Vision blurred—Fluorouracil—head and neck cancer	0.000277	0.00216	CcSEcCtD
Celecoxib—ALB—lymph node—head and neck cancer	0.000276	0.00334	CbGeAlD
Celecoxib—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000274	0.00214	CcSEcCtD
Celecoxib—Pneumonia—Docetaxel—head and neck cancer	0.000273	0.00213	CcSEcCtD
Celecoxib—Anaemia—Fluorouracil—head and neck cancer	0.000271	0.00212	CcSEcCtD
Celecoxib—Infestation NOS—Docetaxel—head and neck cancer	0.000271	0.00212	CcSEcCtD
Celecoxib—Infestation—Docetaxel—head and neck cancer	0.000271	0.00212	CcSEcCtD
Celecoxib—Hypersensitivity—Vinblastine—head and neck cancer	0.000269	0.0021	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000269	0.0021	CcSEcCtD
Celecoxib—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000267	0.00209	CcSEcCtD
Celecoxib—ABCC4—lymph node—head and neck cancer	0.000267	0.00323	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—head and neck cancer	0.000266	0.00322	CbGeAlD
Celecoxib—Myocardial infarction—Docetaxel—head and neck cancer	0.000266	0.00208	CcSEcCtD
Celecoxib—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000266	0.00208	CcSEcCtD
Celecoxib—Stomatitis—Docetaxel—head and neck cancer	0.000264	0.00206	CcSEcCtD
Celecoxib—Jaundice—Docetaxel—head and neck cancer	0.000264	0.00206	CcSEcCtD
Celecoxib—Conjunctivitis—Docetaxel—head and neck cancer	0.000263	0.00206	CcSEcCtD
Celecoxib—Body temperature increased—Hydroxyurea—head and neck cancer	0.000263	0.00206	CcSEcCtD
Celecoxib—Leukopenia—Fluorouracil—head and neck cancer	0.000263	0.00205	CcSEcCtD
Celecoxib—Asthenia—Vinblastine—head and neck cancer	0.000262	0.00205	CcSEcCtD
Celecoxib—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000256	0.002	CcSEcCtD
Celecoxib—Epistaxis—Docetaxel—head and neck cancer	0.000256	0.002	CcSEcCtD
Celecoxib—Agranulocytosis—Docetaxel—head and neck cancer	0.000253	0.00198	CcSEcCtD
Celecoxib—Chest pain—Fluorouracil—head and neck cancer	0.00025	0.00195	CcSEcCtD
Celecoxib—Myalgia—Fluorouracil—head and neck cancer	0.00025	0.00195	CcSEcCtD
Celecoxib—Diarrhoea—Vinblastine—head and neck cancer	0.00025	0.00195	CcSEcCtD
Celecoxib—CA4—lymph node—head and neck cancer	0.000245	0.00297	CbGeAlD
Celecoxib—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000245	0.00192	CcSEcCtD
Celecoxib—Haemoglobin—Docetaxel—head and neck cancer	0.000245	0.00191	CcSEcCtD
Celecoxib—Rhinitis—Docetaxel—head and neck cancer	0.000244	0.00191	CcSEcCtD
Celecoxib—Haemorrhage—Docetaxel—head and neck cancer	0.000243	0.0019	CcSEcCtD
Celecoxib—Hepatitis—Docetaxel—head and neck cancer	0.000243	0.0019	CcSEcCtD
Celecoxib—Hypoaesthesia—Docetaxel—head and neck cancer	0.000242	0.00189	CcSEcCtD
Celecoxib—Confusional state—Fluorouracil—head and neck cancer	0.000241	0.00189	CcSEcCtD
Celecoxib—Pharyngitis—Docetaxel—head and neck cancer	0.000241	0.00189	CcSEcCtD
Celecoxib—Dizziness—Vinblastine—head and neck cancer	0.000241	0.00189	CcSEcCtD
Celecoxib—Urinary tract disorder—Docetaxel—head and neck cancer	0.00024	0.00188	CcSEcCtD
Celecoxib—Oedema peripheral—Docetaxel—head and neck cancer	0.00024	0.00187	CcSEcCtD
Celecoxib—Oedema—Fluorouracil—head and neck cancer	0.000239	0.00187	CcSEcCtD
Celecoxib—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000239	0.00187	CcSEcCtD
Celecoxib—Connective tissue disorder—Docetaxel—head and neck cancer	0.000239	0.00187	CcSEcCtD
Celecoxib—Asthenia—Hydroxyurea—head and neck cancer	0.000239	0.00187	CcSEcCtD
Celecoxib—Urethral disorder—Docetaxel—head and neck cancer	0.000239	0.00186	CcSEcCtD
Celecoxib—Infection—Fluorouracil—head and neck cancer	0.000238	0.00186	CcSEcCtD
Celecoxib—Nervous system disorder—Fluorouracil—head and neck cancer	0.000235	0.00184	CcSEcCtD
Celecoxib—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000234	0.00183	CcSEcCtD
Celecoxib—Tachycardia—Fluorouracil—head and neck cancer	0.000234	0.00183	CcSEcCtD
Celecoxib—Vomiting—Vinblastine—head and neck cancer	0.000232	0.00181	CcSEcCtD
Celecoxib—Erythema multiforme—Docetaxel—head and neck cancer	0.00023	0.0018	CcSEcCtD
Celecoxib—Headache—Vinblastine—head and neck cancer	0.000229	0.00179	CcSEcCtD
Celecoxib—Anorexia—Fluorouracil—head and neck cancer	0.000228	0.00178	CcSEcCtD
Celecoxib—Diarrhoea—Hydroxyurea—head and neck cancer	0.000228	0.00178	CcSEcCtD
Celecoxib—Eye disorder—Docetaxel—head and neck cancer	0.000227	0.00178	CcSEcCtD
Celecoxib—Flushing—Docetaxel—head and neck cancer	0.000226	0.00176	CcSEcCtD
Celecoxib—Cardiac disorder—Docetaxel—head and neck cancer	0.000226	0.00176	CcSEcCtD
Celecoxib—Angiopathy—Docetaxel—head and neck cancer	0.000221	0.00173	CcSEcCtD
Celecoxib—Dizziness—Hydroxyurea—head and neck cancer	0.00022	0.00172	CcSEcCtD
Celecoxib—Immune system disorder—Docetaxel—head and neck cancer	0.00022	0.00172	CcSEcCtD
Celecoxib—Mediastinal disorder—Docetaxel—head and neck cancer	0.000219	0.00171	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000218	0.00171	CcSEcCtD
Celecoxib—Arrhythmia—Docetaxel—head and neck cancer	0.000217	0.0017	CcSEcCtD
Celecoxib—Nausea—Vinblastine—head and neck cancer	0.000217	0.00169	CcSEcCtD
Celecoxib—Insomnia—Fluorouracil—head and neck cancer	0.000217	0.00169	CcSEcCtD
Celecoxib—Paraesthesia—Fluorouracil—head and neck cancer	0.000215	0.00168	CcSEcCtD
Celecoxib—Alopecia—Docetaxel—head and neck cancer	0.000215	0.00168	CcSEcCtD
Celecoxib—PTGS2—head—head and neck cancer	0.000214	0.0026	CbGeAlD
Celecoxib—Dyspnoea—Fluorouracil—head and neck cancer	0.000214	0.00167	CcSEcCtD
Celecoxib—Mental disorder—Docetaxel—head and neck cancer	0.000213	0.00167	CcSEcCtD
Celecoxib—Somnolence—Fluorouracil—head and neck cancer	0.000213	0.00166	CcSEcCtD
Celecoxib—Vomiting—Hydroxyurea—head and neck cancer	0.000212	0.00165	CcSEcCtD
Celecoxib—Dyspepsia—Fluorouracil—head and neck cancer	0.000211	0.00165	CcSEcCtD
Celecoxib—Rash—Hydroxyurea—head and neck cancer	0.00021	0.00164	CcSEcCtD
Celecoxib—Dermatitis—Hydroxyurea—head and neck cancer	0.00021	0.00164	CcSEcCtD
Celecoxib—Headache—Hydroxyurea—head and neck cancer	0.000208	0.00163	CcSEcCtD
Celecoxib—Decreased appetite—Fluorouracil—head and neck cancer	0.000208	0.00163	CcSEcCtD
Celecoxib—Dysgeusia—Docetaxel—head and neck cancer	0.000207	0.00162	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000207	0.00162	CcSEcCtD
Celecoxib—Back pain—Docetaxel—head and neck cancer	0.000205	0.0016	CcSEcCtD
Celecoxib—Muscle spasms—Docetaxel—head and neck cancer	0.000204	0.00159	CcSEcCtD
Celecoxib—CA2—lymph node—head and neck cancer	0.000203	0.00246	CbGeAlD
Celecoxib—Nausea—Hydroxyurea—head and neck cancer	0.000198	0.00154	CcSEcCtD
Celecoxib—Feeling abnormal—Fluorouracil—head and neck cancer	0.000197	0.00154	CcSEcCtD
Celecoxib—Anaemia—Docetaxel—head and neck cancer	0.000196	0.00153	CcSEcCtD
Celecoxib—Urticaria—Fluorouracil—head and neck cancer	0.00019	0.00149	CcSEcCtD
Celecoxib—Syncope—Docetaxel—head and neck cancer	0.00019	0.00148	CcSEcCtD
Celecoxib—Leukopenia—Docetaxel—head and neck cancer	0.00019	0.00148	CcSEcCtD
Celecoxib—Body temperature increased—Fluorouracil—head and neck cancer	0.000189	0.00148	CcSEcCtD
Celecoxib—Palpitations—Docetaxel—head and neck cancer	0.000187	0.00146	CcSEcCtD
Celecoxib—Loss of consciousness—Docetaxel—head and neck cancer	0.000186	0.00145	CcSEcCtD
Celecoxib—Cough—Docetaxel—head and neck cancer	0.000185	0.00144	CcSEcCtD
Celecoxib—CYP2D6—head—head and neck cancer	0.000184	0.00223	CbGeAlD
Celecoxib—Hypertension—Docetaxel—head and neck cancer	0.000183	0.00143	CcSEcCtD
Celecoxib—Myalgia—Docetaxel—head and neck cancer	0.00018	0.00141	CcSEcCtD
Celecoxib—Chest pain—Docetaxel—head and neck cancer	0.00018	0.00141	CcSEcCtD
Celecoxib—Arthralgia—Docetaxel—head and neck cancer	0.00018	0.00141	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000179	0.0014	CcSEcCtD
Celecoxib—Hypersensitivity—Fluorouracil—head and neck cancer	0.000176	0.00138	CcSEcCtD
Celecoxib—Dry mouth—Docetaxel—head and neck cancer	0.000176	0.00138	CcSEcCtD
Celecoxib—Confusional state—Docetaxel—head and neck cancer	0.000174	0.00136	CcSEcCtD
Celecoxib—Anaphylactic shock—Docetaxel—head and neck cancer	0.000173	0.00135	CcSEcCtD
Celecoxib—Oedema—Docetaxel—head and neck cancer	0.000173	0.00135	CcSEcCtD
Celecoxib—Infection—Docetaxel—head and neck cancer	0.000172	0.00134	CcSEcCtD
Celecoxib—Shock—Docetaxel—head and neck cancer	0.00017	0.00133	CcSEcCtD
Celecoxib—Nervous system disorder—Docetaxel—head and neck cancer	0.00017	0.00132	CcSEcCtD
Celecoxib—Pruritus—Fluorouracil—head and neck cancer	0.000169	0.00132	CcSEcCtD
Celecoxib—Thrombocytopenia—Docetaxel—head and neck cancer	0.000169	0.00132	CcSEcCtD
Celecoxib—Tachycardia—Docetaxel—head and neck cancer	0.000169	0.00132	CcSEcCtD
Celecoxib—Skin disorder—Docetaxel—head and neck cancer	0.000168	0.00131	CcSEcCtD
Celecoxib—Anorexia—Docetaxel—head and neck cancer	0.000165	0.00129	CcSEcCtD
Celecoxib—Diarrhoea—Fluorouracil—head and neck cancer	0.000164	0.00128	CcSEcCtD
Celecoxib—Dizziness—Fluorouracil—head and neck cancer	0.000158	0.00124	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000157	0.00123	CcSEcCtD
Celecoxib—Insomnia—Docetaxel—head and neck cancer	0.000156	0.00122	CcSEcCtD
Celecoxib—Paraesthesia—Docetaxel—head and neck cancer	0.000155	0.00121	CcSEcCtD
Celecoxib—Dyspnoea—Docetaxel—head and neck cancer	0.000154	0.0012	CcSEcCtD
Celecoxib—Somnolence—Docetaxel—head and neck cancer	0.000154	0.0012	CcSEcCtD
Celecoxib—Vomiting—Fluorouracil—head and neck cancer	0.000152	0.00119	CcSEcCtD
Celecoxib—Dyspepsia—Docetaxel—head and neck cancer	0.000152	0.00119	CcSEcCtD
Celecoxib—Rash—Fluorouracil—head and neck cancer	0.000151	0.00118	CcSEcCtD
Celecoxib—Dermatitis—Fluorouracil—head and neck cancer	0.000151	0.00118	CcSEcCtD
Celecoxib—Decreased appetite—Docetaxel—head and neck cancer	0.00015	0.00117	CcSEcCtD
Celecoxib—PTGS2—lymph node—head and neck cancer	0.00015	0.00182	CbGeAlD
Celecoxib—Headache—Fluorouracil—head and neck cancer	0.00015	0.00117	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000149	0.00117	CcSEcCtD
Celecoxib—Fatigue—Docetaxel—head and neck cancer	0.000149	0.00116	CcSEcCtD
Celecoxib—Constipation—Docetaxel—head and neck cancer	0.000148	0.00116	CcSEcCtD
Celecoxib—Feeling abnormal—Docetaxel—head and neck cancer	0.000142	0.00111	CcSEcCtD
Celecoxib—Nausea—Fluorouracil—head and neck cancer	0.000142	0.00111	CcSEcCtD
Celecoxib—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000141	0.0011	CcSEcCtD
Celecoxib—Body temperature increased—Docetaxel—head and neck cancer	0.000137	0.00107	CcSEcCtD
Celecoxib—Abdominal pain—Docetaxel—head and neck cancer	0.000137	0.00107	CcSEcCtD
Celecoxib—Hypersensitivity—Docetaxel—head and neck cancer	0.000127	0.000995	CcSEcCtD
Celecoxib—Asthenia—Docetaxel—head and neck cancer	0.000124	0.000969	CcSEcCtD
Celecoxib—Pruritus—Docetaxel—head and neck cancer	0.000122	0.000956	CcSEcCtD
Celecoxib—Diarrhoea—Docetaxel—head and neck cancer	0.000118	0.000924	CcSEcCtD
Celecoxib—Dizziness—Docetaxel—head and neck cancer	0.000114	0.000893	CcSEcCtD
Celecoxib—Vomiting—Docetaxel—head and neck cancer	0.00011	0.000859	CcSEcCtD
Celecoxib—Rash—Docetaxel—head and neck cancer	0.000109	0.000852	CcSEcCtD
Celecoxib—Dermatitis—Docetaxel—head and neck cancer	0.000109	0.000851	CcSEcCtD
Celecoxib—Headache—Docetaxel—head and neck cancer	0.000108	0.000846	CcSEcCtD
Celecoxib—Nausea—Docetaxel—head and neck cancer	0.000103	0.000803	CcSEcCtD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.27e-05	0.000214	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.26e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CASP8—head and neck cancer	3.24e-05	0.000213	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.22e-05	0.000211	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.22e-05	0.000211	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.21e-05	0.000211	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—head and neck cancer	3.21e-05	0.000211	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTEN—head and neck cancer	3.17e-05	0.000208	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—PIK3CA—head and neck cancer	3.13e-05	0.000205	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—BCL2—head and neck cancer	3.12e-05	0.000205	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—head and neck cancer	3.11e-05	0.000204	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTEN—head and neck cancer	3.08e-05	0.000202	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTEN—head and neck cancer	3.08e-05	0.000202	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—head and neck cancer	3.06e-05	0.000201	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.04e-05	0.0002	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	3.03e-05	0.000199	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—head and neck cancer	3e-05	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—PIK3CA—head and neck cancer	3e-05	0.000197	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—YAP1—head and neck cancer	2.97e-05	0.000195	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—head and neck cancer	2.94e-05	0.000193	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.9e-05	0.00019	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.9e-05	0.00019	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.9e-05	0.00019	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—head and neck cancer	2.89e-05	0.00019	CbGpPWpGaD
Celecoxib—MAPK14—Metabolism of mRNA—AKT1—head and neck cancer	2.88e-05	0.000189	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTEN—head and neck cancer	2.88e-05	0.000189	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—UROD—head and neck cancer	2.87e-05	0.000188	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.87e-05	0.000188	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	2.86e-05	0.000188	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—PIK3CA—head and neck cancer	2.85e-05	0.000187	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—AKT1—head and neck cancer	2.84e-05	0.000186	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—BCL2—head and neck cancer	2.78e-05	0.000183	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—head and neck cancer	2.78e-05	0.000182	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—head and neck cancer	2.74e-05	0.00018	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—head and neck cancer	2.73e-05	0.000179	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NAT2—head and neck cancer	2.73e-05	0.000179	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	2.73e-05	0.000179	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—head and neck cancer	2.72e-05	0.000178	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTEN—head and neck cancer	2.67e-05	0.000175	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—head and neck cancer	2.64e-05	0.000173	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—head and neck cancer	2.64e-05	0.000173	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PTEN—head and neck cancer	2.58e-05	0.000169	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOTCH1—head and neck cancer	2.58e-05	0.000169	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—AKT1—head and neck cancer	2.55e-05	0.000168	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.51e-05	0.000165	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—MAPK3—head and neck cancer	2.5e-05	0.000164	CbGpPWpGaD
Celecoxib—MAPK14—Metabolism of RNA—AKT1—head and neck cancer	2.47e-05	0.000162	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—AKT1—head and neck cancer	2.45e-05	0.000161	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—head and neck cancer	2.44e-05	0.00016	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.43e-05	0.00016	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—MAPK3—head and neck cancer	2.41e-05	0.000158	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DPYD—head and neck cancer	2.39e-05	0.000157	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTEN—head and neck cancer	2.38e-05	0.000156	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—MAPK1—head and neck cancer	2.38e-05	0.000156	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—head and neck cancer	2.36e-05	0.000155	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.34e-05	0.000154	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—head and neck cancer	2.34e-05	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—STAT3—head and neck cancer	2.33e-05	0.000153	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—AKT1—head and neck cancer	2.33e-05	0.000153	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.32e-05	0.000152	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	2.32e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—head and neck cancer	2.31e-05	0.000152	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—STAT3—head and neck cancer	2.31e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2L1—head and neck cancer	2.31e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PTEN—head and neck cancer	2.3e-05	0.000151	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—MAPK1—head and neck cancer	2.3e-05	0.000151	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—head and neck cancer	2.3e-05	0.000151	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—YAP1—head and neck cancer	2.27e-05	0.000149	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PIK3CA—head and neck cancer	2.23e-05	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MAPK3—head and neck cancer	2.23e-05	0.000146	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NAT2—head and neck cancer	2.21e-05	0.000145	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MAPK3—head and neck cancer	2.21e-05	0.000145	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—PIK3CA—head and neck cancer	2.2e-05	0.000144	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	2.19e-05	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—MAPK3—head and neck cancer	2.19e-05	0.000143	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PIK3CA—head and neck cancer	2.18e-05	0.000143	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PIK3CA—head and neck cancer	2.18e-05	0.000143	CbGpPWpGaD
Celecoxib—PDPK1—Disease—STAT3—head and neck cancer	2.13e-05	0.00014	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTEN—head and neck cancer	2.13e-05	0.00014	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MAPK1—head and neck cancer	2.12e-05	0.000139	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—head and neck cancer	2.12e-05	0.000139	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MAPK1—head and neck cancer	2.1e-05	0.000138	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—head and neck cancer	2.1e-05	0.000138	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	2.09e-05	0.000137	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—MAPK1—head and neck cancer	2.08e-05	0.000137	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PIK3CA—head and neck cancer	2.06e-05	0.000135	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NOTCH1—head and neck cancer	2.06e-05	0.000135	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.05e-05	0.000135	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTEN—head and neck cancer	2.04e-05	0.000134	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MAPK3—head and neck cancer	2.04e-05	0.000134	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PIK3CA—head and neck cancer	2.03e-05	0.000133	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—head and neck cancer	1.99e-05	0.000131	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PIK3CA—head and neck cancer	1.99e-05	0.000131	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—head and neck cancer	1.97e-05	0.000129	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK3—head and neck cancer	1.97e-05	0.000129	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MAPK1—head and neck cancer	1.94e-05	0.000127	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—head and neck cancer	1.94e-05	0.000127	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DPYD—head and neck cancer	1.94e-05	0.000127	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.92e-05	0.000126	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—head and neck cancer	1.91e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.9e-05	0.000125	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CASP8—head and neck cancer	1.89e-05	0.000124	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PIK3CA—head and neck cancer	1.88e-05	0.000124	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK1—head and neck cancer	1.87e-05	0.000123	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—head and neck cancer	1.87e-05	0.000123	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDH1—head and neck cancer	1.86e-05	0.000122	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—head and neck cancer	1.84e-05	0.000121	CbGpPWpGaD
Celecoxib—ALB—Metabolism—YAP1—head and neck cancer	1.84e-05	0.000121	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AKT1—head and neck cancer	1.82e-05	0.00012	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NAT2—head and neck cancer	1.82e-05	0.00012	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PIK3CA—head and neck cancer	1.82e-05	0.00012	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.81e-05	0.000119	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NAT2—head and neck cancer	1.81e-05	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PIK3CA—head and neck cancer	1.8e-05	0.000118	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AKT1—head and neck cancer	1.79e-05	0.000118	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AKT1—head and neck cancer	1.78e-05	0.000117	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AKT1—head and neck cancer	1.78e-05	0.000117	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—head and neck cancer	1.77e-05	0.000116	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—head and neck cancer	1.75e-05	0.000115	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—head and neck cancer	1.73e-05	0.000114	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTEN—head and neck cancer	1.72e-05	0.000113	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—head and neck cancer	1.7e-05	0.000112	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—head and neck cancer	1.69e-05	0.000111	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—head and neck cancer	1.68e-05	0.000111	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PIK3CA—head and neck cancer	1.68e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—head and neck cancer	1.67e-05	0.00011	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTEN—head and neck cancer	1.67e-05	0.00011	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—head and neck cancer	1.66e-05	0.000109	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—head and neck cancer	1.63e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PIK3CA—head and neck cancer	1.62e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2—head and neck cancer	1.62e-05	0.000106	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DPYD—head and neck cancer	1.6e-05	0.000105	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DPYD—head and neck cancer	1.58e-05	0.000104	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—head and neck cancer	1.56e-05	0.000102	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—head and neck cancer	1.54e-05	0.000101	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—YAP1—head and neck cancer	1.52e-05	9.96e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—head and neck cancer	1.51e-05	9.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—YAP1—head and neck cancer	1.5e-05	9.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—head and neck cancer	1.5e-05	9.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—head and neck cancer	1.5e-05	9.87e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PIK3CA—head and neck cancer	1.5e-05	9.85e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—head and neck cancer	1.49e-05	9.8e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.49e-05	9.77e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—head and neck cancer	1.49e-05	9.77e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.48e-05	9.71e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—head and neck cancer	1.47e-05	9.68e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PIK3CA—head and neck cancer	1.44e-05	9.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK3—head and neck cancer	1.43e-05	9.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—head and neck cancer	1.43e-05	9.36e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—head and neck cancer	1.41e-05	9.23e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.38e-05	9.06e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—head and neck cancer	1.37e-05	9.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TYMS—head and neck cancer	1.36e-05	8.95e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK1—head and neck cancer	1.36e-05	8.91e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—head and neck cancer	1.36e-05	8.91e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—head and neck cancer	1.35e-05	8.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTEN—head and neck cancer	1.34e-05	8.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOTCH1—head and neck cancer	1.34e-05	8.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—head and neck cancer	1.33e-05	8.71e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—head and neck cancer	1.29e-05	8.47e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP1A1—head and neck cancer	1.28e-05	8.39e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—head and neck cancer	1.23e-05	8.05e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOTCH1—head and neck cancer	1.22e-05	8.02e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PIK3CA—head and neck cancer	1.21e-05	7.96e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.2e-05	7.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—head and neck cancer	1.2e-05	7.88e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—head and neck cancer	1.19e-05	7.84e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAT2—head and neck cancer	1.19e-05	7.82e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PIK3CA—head and neck cancer	1.18e-05	7.73e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—head and neck cancer	1.18e-05	7.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK3—head and neck cancer	1.15e-05	7.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MAPK3—head and neck cancer	1.14e-05	7.48e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—head and neck cancer	1.14e-05	7.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.13e-05	7.42e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK3—head and neck cancer	1.13e-05	7.42e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TYMS—head and neck cancer	1.1e-05	7.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK1—head and neck cancer	1.09e-05	7.16e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—head and neck cancer	1.09e-05	7.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—head and neck cancer	1.09e-05	7.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—head and neck cancer	1.09e-05	7.15e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK1—head and neck cancer	1.08e-05	7.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.05e-05	6.89e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DPYD—head and neck cancer	1.05e-05	6.86e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—head and neck cancer	1.04e-05	6.86e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1A1—head and neck cancer	1.03e-05	6.79e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—YAP1—head and neck cancer	9.92e-06	6.51e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—head and neck cancer	9.91e-06	6.5e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.85e-06	6.47e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—head and neck cancer	9.62e-06	6.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PIK3CA—head and neck cancer	9.46e-06	6.21e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CA—head and neck cancer	9.33e-06	6.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—head and neck cancer	9.22e-06	6.05e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TYMS—head and neck cancer	9.11e-06	5.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TYMS—head and neck cancer	9.03e-06	5.93e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—head and neck cancer	9.03e-06	5.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—head and neck cancer	9e-06	5.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—head and neck cancer	8.99e-06	5.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—head and neck cancer	8.93e-06	5.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—head and neck cancer	8.76e-06	5.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTEN—head and neck cancer	8.67e-06	5.69e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—head and neck cancer	8.63e-06	5.67e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—head and neck cancer	8.62e-06	5.66e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—head and neck cancer	8.55e-06	5.61e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1A1—head and neck cancer	8.54e-06	5.6e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.49e-06	5.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1A1—head and neck cancer	8.46e-06	5.55e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTEN—head and neck cancer	7.91e-06	5.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—head and neck cancer	7.83e-06	5.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—head and neck cancer	7.76e-06	5.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—head and neck cancer	7.73e-06	5.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—head and neck cancer	7.69e-06	5.05e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—head and neck cancer	7.62e-06	5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK3—head and neck cancer	7.41e-06	4.86e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—head and neck cancer	7.08e-06	4.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK1—head and neck cancer	7.05e-06	4.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—head and neck cancer	7.05e-06	4.63e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.95e-06	4.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK3—head and neck cancer	6.76e-06	4.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTEN—head and neck cancer	6.63e-06	4.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK1—head and neck cancer	6.43e-06	4.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—head and neck cancer	6.43e-06	4.22e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—head and neck cancer	6.15e-06	4.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CA—head and neck cancer	6.12e-06	4.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TYMS—head and neck cancer	5.96e-06	3.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—head and neck cancer	5.92e-06	3.89e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—head and neck cancer	5.89e-06	3.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—head and neck cancer	5.66e-06	3.72e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—head and neck cancer	5.64e-06	3.7e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CA—head and neck cancer	5.58e-06	3.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.58e-06	3.66e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTEN—head and neck cancer	5.36e-06	3.52e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—head and neck cancer	5.16e-06	3.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.08e-06	3.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.03e-06	3.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—head and neck cancer	5e-06	3.28e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CA—head and neck cancer	4.68e-06	3.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—head and neck cancer	4.56e-06	2.99e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTEN—head and neck cancer	4.43e-06	2.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTEN—head and neck cancer	4.39e-06	2.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—head and neck cancer	3.82e-06	2.51e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CA—head and neck cancer	3.78e-06	2.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.32e-06	2.18e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.12e-06	2.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.1e-06	2.03e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—head and neck cancer	3.09e-06	2.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTEN—head and neck cancer	2.89e-06	1.9e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—head and neck cancer	2.55e-06	1.67e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—head and neck cancer	2.53e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.04e-06	1.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—head and neck cancer	1.67e-06	1.09e-05	CbGpPWpGaD
